INTRODUCTION
============

Various factors affect the coevolution of pathogenic bacteria and plants, such as plant immunity, elicitors, and interactions among pathogen-derived effectors ([@b46-molce-42-503]). The first defense mechanism comprises transmembrane pattern recognition receptors (PRRs), which recognize pathogen- or microbial-associated molecular patterns (PAMPs or MAMPs) ([@b52-molce-42-503]), thereby initiating PAMP/MAMP-triggered immunity (PTI). PTI includes defense gene activation, oxidative burst, ion fluxes, callose deposition, hormonal action, stomatal closure, and gene silencing ([@b36-molce-42-503]). Pathogens overcome PTI through the use of effectors and toxins. The second defense mechanism, ETI comprises an interplay between pathogen-employed effectors and the polymorphic nucleotide-binding site leucine-rich repeat (NB-LRR) proteins encoded by most *R* genes in plants. This interaction between effectors and NB-LRR proteins could be direct or indirect; for example, the NB-LRR protein could guard an effector target protein (guard model) ([@b23-molce-42-503]); another host protein could evolve with a similar binding site, such as an effector target protein (decoy model) ([@b49-molce-42-503]); or NB-LRR may form a complex with an additional protein domain that helps identify pathogen effectors ([@b43-molce-42-503]), modification of which activates the resistance proteins. Both direct and indirect interactions activate NB-LRR proteins and initiate defense signaling. Many effectors suppress one or more components of PTI to promote nutrient leakage, pathogen dispersal, and bacterial growth ([@b44-molce-42-503]). The RPM1-interacting protein 4 (RIN4) is a small protein of 211 amino acids (aa) guarded by two resistance proteins, RPM1 and RPS2. RIN4 plays an important role in regulating PTI and ETI. In this mini-review, we discuss interactions of RIN4 with various proteins and the mechanism of RIN4 modification by various effectors. We also speculate the function of RIN4 in PTI, ETI, and intercellular immune signaling.

RIN4 ACTS AS A MOLECULAR SWITCH WHEN REGULATING PTI
===================================================

It was reported before that RIN4 is a negative regulator of PTI; absence of RIN4 enhances PAMP-induced response ([Fig. 1A](#f1-molce-42-503){ref-type="fig"}), whereas *RIN4* overexpression inhibits PTI. RIN4 controls callose deposition upon PAMP perception; no callose deposition is observed with flg22 or *Pto hrcC* infiltration of plants overexpressing RIN4. RIN4-mediated PTI signaling is independent of AvrRpt2, AvrRpm1, RPM1, and RPS2. *Pseudomonas syringae* effectors AvrRpm1 and AvrRpt2 modify RIN4 to inhibit PTI signaling ([Fig. 1C](#f1-molce-42-503){ref-type="fig"}) ([@b25-molce-42-503]). RIN4 derivatives lacking C-terminal Cys residues as well as RIN4 fragments cleaved by AvrRpt2 are hyperactive PTI suppressors ([@b1-molce-42-503]). The NOI (No~3~-induced) domains of RIN4 play important roles in suppressing PTI. RIN4 contains two NOI domains at N-terminal (aa 6-42) and C-terminal (aa 145-187) end of the protein. N-NOI domain contains conserved motif PxFGxW^6--12^ required for effector mediated RIN4 cleavage and C-NOI domain contains two conserved sequence, Y/FTxxF^165--169^ for effector mediated RIN4 phosphorylation and PxFGxW^145--156^ for RIN4 cleavage. RIN4 derivatives lacking both NOI domains are unable to suppress PTI; however, the presence of a single NOI domain was enough to suppress effective defense against *Pto hrcC*, but only the N-NOI domain suppressed flg22-induced callose deposition ([@b1-molce-42-503]). During pathogen invasion, stomata act as an active regulator of plant immune responses. Immediately after bacteria infiltrate the plant, stomata close (within 1 h); however, virulent bacteria use the coronatine insensitive1 (COI1)-dependent pathway ([@b19-molce-42-503]) to reopen the stomata (within 3 h) ([@b29-molce-42-503]). Several bacteria and fungi control stomata during pathogen infection ([@b2-molce-42-503]; [@b4-molce-42-503]; [@b38-molce-42-503]). Activation and inactivation of plasma membrane H^+^-ATPase (proton pump) control the opening and closing of stomata. The C-terminal end of H^+^-ATPase inhibits proton pump activation under normal conditions ([Fig. 1D](#f1-molce-42-503){ref-type="fig"}). RIN4 is expressed in guard cells and mesophyll cells ([@b29-molce-42-503]), and positively regulates stomatal apertures by controlling H^+^-ATPase activity. RIN4 interacts with the C-terminal end of AHA1^837--950^ and AHA2^837--949^ in yeast two-hybrid assay and bimolecular fluorescence complementation (BiFC) assay ([@b28-molce-42-503]). Increased phosphorylation of RIN4 accelerates AHA activity because of a strong association between RIN4 and AHA ([Fig. 1E](#f1-molce-42-503){ref-type="fig"}) ([@b26-molce-42-503]; [@b29-molce-42-503]). RIN4 and a receptor-like cytoplasmic kinase (RLCK) RPM1-induced protein kinase (RIPK) are crucial for stomatal regulation; this is indicated by the inability of coronatine to reopen stomata in *rin4* and *ripk* mutant plants ([@b26-molce-42-503]; [@b28-molce-42-503]). Under normal conditions, the basal level of phosphorylated RIN4^S141^ (pRIN4^S141^) is low. The level of phosphorylation increases greatly upon the sensing of flg22 by FLS2 ([Fig. 1B](#f1-molce-42-503){ref-type="fig"}), which initiates several immune outputs such as callose deposition, ROS burst, and defense gene expression. BIK1 and/or PBL1 are sufficient for induced level of phosphorylated RIN4^S141^ ([@b10-molce-42-503]). Plants maintain a basal level of phosphorylated RIN4^T166^ (pRIN4^T166^) under normal conditions, possibly for regular stomatal regulation ([@b26-molce-42-503]). Pathogens deploy effectors to induce RIPK-mediated phosphorylation of RIN4 at T166 to suppress PTI, reopen stomata and effector triggered susceptibility ([Figs. 1C and 1E](#f1-molce-42-503){ref-type="fig"}). It is possible that pathogens accelerate the pre-established process of stomata opening to enter the cells using the virulence of effector proteins. All these data clearly indicate RIN4 act as a molecular switch to regulate PTI responses. It is not yet clear why AvrRpt2 cleaves a negative regulator of PTI; however, a recent study indicates that AvrRpt2 cleavage products are also hyperactive PTI suppressors ([@b1-molce-42-503]). HopF2 inhibits stomatal closure during *Pst* infection ([@b20-molce-42-503]). In the plasma membrane, both RIN4 and HopF2 interact with AHA2 and other proteins ([@b26-molce-42-503]; [@b28-molce-42-503]). HopF2 has also been reported to suppress AvrRpt2-mediated RIN4 degradation ([@b50-molce-42-503]), suggesting that an increase in the level of RIN4 leads to greater activation of H^+^-ATPase. Pathogens evolve simultaneously with the plant immune system and introduce new effectors to modulate stomatal immunity.

RIN4 IS A MULTI-EFFECTOR TARGET PROTEIN CRITICAL FOR PATHOGEN VIRULENCE AND NLR-MEDIATED ETI
============================================================================================

Since RIN4 is an important regulator of PTI, it is expected that pathogens will try to modify RIN4 using various effectors. RIN4 is guarded by two NB-LRR proteins, which recognize RIN4 modifications ([Table 1](#t1-molce-42-503){ref-type="table"}) caused by three *P. syringae* type III effectors, including AvrB, AvrRpm1, and AvrRpt2 ([Table 2](#t2-molce-42-503){ref-type="table"}). A recent study has identified new effectors that modify RIN4 or interfere with other effector-mediated RIN4 modifications. Here, we discuss the mechanisms of RIN4 modifications mediated by different effectors, and related resistance proteins involved in the defense signaling pathway.

Both AvrRpm1- and AvrB-maturation is critical for RIN4-effector interaction
---------------------------------------------------------------------------

To inactivate PTI via RIN4 modification, pathogens inject type III effectors AvrRpm1 and AvrB into the plant cell. Both effectors have no sequence homology, except in the N-terminal region. After delivery, both effectors undergo myristoylation of glycine 2 (Gly2) residue and palmitoylation of Cys3 to ensure their proper localization to the plasma membrane. Both these sites are required for maximum virulence. Palmitoylation often requires previous myristoylation ([@b9-molce-42-503]; [@b22-molce-42-503]; [@b37-molce-42-503]). In the plant cell membrane, AvrRpm1 and AvrB interact with RIN4, as shown by co-immunoprecipitation experiments ([@b34-molce-42-503]). AvrB has two groups of residues that interact with RIN4. The first group comprises T^125^ and H^217^ residues, and the second group comprises Q^208^, R^209^, and Y^210^ residues; both these groups of residues interact with Y^165^, T^166^, H^167^, and F^169^ residues of RIN4 ([@b16-molce-42-503]). Among these residues, F^169^ is very important for the interaction of RIN4 with AvrB; it also plays important role during RIN4--RPM1 interaction and RPM1 accumulation ([@b9-molce-42-503]). Physical interaction between RIN4 and AvrB is required for the activation of RPM1; however, RPM1 is not required for the interaction with and phosphorylation of RIN4 induced by AvrRpm1 and AvrB ([@b34-molce-42-503]).

AvrB-induced RIN4 phosphorylation through host kinases is critical for immune response and phytohormone regulation
------------------------------------------------------------------------------------------------------------------

Phosphorylation of RIN4 at T^21^, S^160^, and T^166^ residues promotes bacterial virulence; however, S^160^ is not conserved among land plants ([@b1-molce-42-503]; [@b26-molce-42-503]). On the other hand, RIN4^T166^ and RIN4^S141^ are evolutionarily conserved among orthologous RIN4 sequences in different plant species ([@b10-molce-42-503]). AvrB uses RIPK to increase phosphorylated RIN4^T166^ which is epistatic to all PTI outputs enhanced by PAMP-induced accumulation of pRIN4^S141^ ([Fig. 2A](#f2-molce-42-503){ref-type="fig"}). This suggests that pathogens inject effector proteins to increase the level of pRIN4^T166^ and decrease PTI. RIPK also interacts with and phosphorylates AvrB but does not interact with AvrRpt2, AvrPto, AvrPtoB, and AvrRps4, indicating that the RIPK--AvrB interaction is highly specific ([@b30-molce-42-503]). This specific interaction between RIPK and AvrB in accordance with five other RLCK members enhances the phosphorylation activity or substrate specificity of RIPK, resulting in increased phosphorylation of RIN4^T166^. The type III effector AvrPphB, a cysteine protease, cleaves RIPK and other RLCK family members ([@b51-molce-42-503]) and blocks AvrB recognition by RPM1 ([@b1-molce-42-503]). Another effector, HopF2, also targets RIN4 for its virulence ([@b50-molce-42-503]), and inhibits the accumulation of pRIN4^S141^ ([@b10-molce-42-503]). The cumulative effect of multiple effectors decreases the level of pRIN4^S141^ and suppresses PTI.

AvrB also forms a complex with other molecular chaperones, such as HSP90--RAR1-SGT1, to induce plant susceptibility ([@b6-molce-42-503]; [@b13-molce-42-503]; [@b45-molce-42-503]). To enhance virulence and modulate plant hormone signaling, AvrB interacts with and phosphorylates MAP KINASE 4 (MPK4) in an RPM1-independent manner. MPK4 also interacts with and phosphorylates recombinant RIN4, suggesting that RIN4 is a substrate of MPK4. RIN4 positively modulates jasmonic acid signaling. The AvrB--MPK4 and MPK4--RIN4 interactions coupled with RAR1, SGT1, and HSP90 constitute a new pathway for regulating hormone signaling ([@b13-molce-42-503]). AvrB targets host protein kinases, such as RIPK and MPK4, for modulating their activity and/or substrate specificity and for increasing plant susceptibility. Further investigation of the association between RIN4 and other kinases will help unravel the importance of this plant immune regulator in the modulation of PTI/ETI.

AvrRpm1 mediated RIN4 phosphorylation activates both RPM1 and RPS2
------------------------------------------------------------------

[@b34-molce-42-503] have shown AvrRpm1--RIN4 interaction via co-immunoprecipitation experiments ([Table 2](#t2-molce-42-503){ref-type="table"}). However, no interaction has been observed between AvrRpm1 and RIN4 in yeast two-hybrid assays ([@b9-molce-42-503]). RIN4 is not a target of AvrRpm1 alone, as it shows higher virulence in all *rpm1* and *rpm1 rps2 rin4* mutant plants ([@b6-molce-42-503]). AvrRpm1 induces phosphorylation of RIN4; however, RIN4 phosphorylation does not show a consistent decrease in *ripk* mutant background, suggesting that other kinases from the RLCK family are involved in RIN4 phosphorylation ([@b30-molce-42-503]). AvrPphB-mediated RIPK cleavage fails to inhibit AvrRpm1-mediated RPM1 activation, thus supporting previous data ([@b41-molce-42-503]). Increased RIN4^T166^ phosphorylation is observed in the presence of AvrRpm1 both in Arabidopsis and tobacco, but this phosphorylation partially activates AvrRpm1-triggered RPM1 defense signaling. Both AvrRpm1 and AvrB co-immunoprecipitate with RIN4 and AvrB induces phosphorylation of conserved threonine residue at position 166 of RIN4 ([@b9-molce-42-503]). Despite the classical gene-for-gene activation of RPM1, AvrRpm1 also induces RPS2-mediated defense signaling ([@b24-molce-42-503]). A recent study describes that AvrRpm1 induces virulence through COI1-mediated suppression of salicylic acid (SA)-dependent or independent defense signaling pathways ([@b19-molce-42-503]). PARP-1s are proteins that contain extra domains beyond the canonical catalytic domain. They typically facilitate the ribosylation reaction using the catalytic triad. AvrRpm1 has a fold homologous to the active catalytic triad (H^63^-Y^122^-D^185^) of poly-ADP-ribosyl-polymerase-1 (PARP-1) and key structural components of PARP-1. This catalytic activity of AvrRmp1 is required for virulence in a susceptible host, or to activate RPM1-mediated defense signaling. Catalytically inactive AvrRpm1 inhibits the growth of *P. syringae* pv. *maculicola* 1 on susceptible plants through RPS2-mediated defense signaling. These data suggest that AvrRpm1 mimics ADP ribosyl transferase ([@b7-molce-42-503]); however, further investigation is required to establish the ribosyl-transferase activity of AvrRpm1.

AvrB- or AvrRpm1-mediated RIN4^T166^ phosphorylation activates RPM1
-------------------------------------------------------------------

Among the 211 aa of RIN4, aa 141-176 are necessary for phosphorylation, with the threonine (Thr) residue at position 166 being critical for RPM1 activation. Both Avr proteins, AvrB and AvrRpm1, phosphorylate RIN4^T166^ *in vivo* and ultimately activate RPM1 ([Fig. 2B](#f2-molce-42-503){ref-type="fig"}), as it recognizes effector-mediated RIN4 phosphorylation in planta ([@b9-molce-42-503]; [@b30-molce-42-503]). The level of activation of RPM1 is regulated by ROC1, which exists in multiple cellular compartments ([@b18-molce-42-503]). ROC1 interacts with RIN4^142--211^ and exhibits prolyl-peptidyl isomerase (PPIase) activity, which modifies RIN4 configuration by catalyzing cis/trans isomerization of RIN4^P149^ (144-KVTVVPKFGDWD-155) and suppresses RPM1- as well as RPS2-dependent ETI. Mutation of ROC1 at R62 residue completely disrupts its PPIase activity whereas mutation of ROC1 at S58 increases the PPIase activity of ROC1. This RIN4--ROC1 interaction inhibits AvrB- or AvrRpm1-induced phosphorylation of RIN4 and the dissociation of ROC1 from RIN4 or deletion of RIN4^P149^ activates RPM1. Isomerization status of RIN4^P149^ residue can modulate proper conformational change upon induced RIN4^T166^ phosphorylation by effector proteins. In other word, RPM1 can monitor conformational change of RIN4 mediated by T166 phosphorylation and ROC1 plays a role in this conformational change on RIN4 along with T166 phosphorylation ([@b9-molce-42-503]; [@b27-molce-42-503]).

AvrRpt2-mediated cleavage and degradation of RIN4 activates RPS2
----------------------------------------------------------------

AvrRpt2 is a cysteine protease that cleaves the membrane localized Arabidopsis protein RIN4. After delivery inside the cell AvrRpt2 cleaves itself at N terminal region between G^71^-G^72^ in presence of host cyclophilin ROC1 ([@b21-molce-42-503]) and activated AvrRpt*2* associates with PM through myristoylation (Toruno et al., 2018). ROC1 associates with RIN4 and enforces T166 phosphorylation to enhance RPM1-mediated response ([@b27-molce-42-503]). RPS2 and RIN4 are also localized to the plasma membrane ([@b5-molce-42-503]; [@b21-molce-42-503]; [@b34-molce-42-503]). Among these proteins, RPS2 acts as an integral membrane protein because high salt, urea, or pH is unable to remove RPS2 from the membrane ([@b5-molce-42-503]; [@b21-molce-42-503]; [@b34-molce-42-503]). In the absence of RPS2, AvrRpt2 promotes bacterial growth through COI1-mediated suppression of both SA-dependent and -independent defense signaling ([@b19-molce-42-503]). The AvrRpt2-dependent RIN4 degradation is independent of the RPS2 but involves NDR1 and RAR1 ([Fig. 2C](#f2-molce-42-503){ref-type="fig"}) ([@b35-molce-42-503]; [@b47-molce-42-503]). RPS2 is unable to recognize AvrRpt2 directly; instead, it identifies RIN4 degradation and then initiates defense signaling ([@b5-molce-42-503]; [@b34-molce-42-503]). AvrRpt2 cleaves itself and other proteins within a conserved sequence (V/I/L) PxFGxW motif ([@b8-molce-42-503]). RIN4 has two cleavage sites related to AvrRpt2 cleavage sites: RIN4 cleavage site 1 (RCS1; 3-14 aa) and RCS2 (145-156 aa). Cleavage at RCS1 results in 22.2 kDa and 1.2 kDa fragments; cleavage at RCS2 results in 17 kDa and 6.4 kDa fragments; and cleavage at both RCS1 and RCS2 results in 15.9 kDa, 6.4 kDa, and 1.2 kDa fragments. After AvrRpt2 cleaves at RCS2, the 6.4 kDa product remains in the plasma membrane, indicating its membrane localization. After cleavage at RCS2, RIN4 is released from the membrane and the cleavage products undergo proteasome-dependent degradation, as indicated by the inhibition of degradation by the proteasome inhibitor ([@b8-molce-42-503]; [@b24-molce-42-503]).

RIN4 degradation inappropriately activates RPS2-mediated defense signaling
--------------------------------------------------------------------------

RPS2 is an integral membrane protein, which shows direct or indirect interaction with RIN4 in the plant cell. RPS2 recognizes RIN4 degradation and shows a hypersensitive response; thus the *rin4* knockout mutation is viable only in the *rps2* mutant background ([@b34-molce-42-503]). Only the C-terminal half of RIN4 is required for the negative regulation of and association with RPS2. Cleavage of RIN4 removes the negative regulation of RPS2, thereby activating RPS2 ([Fig. 2D](#f2-molce-42-503){ref-type="fig"}). Deletion of 6-9 aa from the C-terminal end of RIN4 results in the complete loss of RPS2 regulation by RIN4 ([@b14-molce-42-503]). A recent study has shown that RIN4^P149^ acts as a conformational switch, which regulates RPS2 activation ([@b27-molce-42-503]). ROC1 suppresses RPS2 activation through its PPlase activity to isomerize RIN4^P149^ by interacting with the C-terminal end of RIN4^142--210^. The RIN4--ROC1 complex dissociates following AvrB- or AvrRpm1-induced RIN4^T166^ phosphorylation. The dissociation of ROC1 from RIN4 or deletion of RIN4^P149^ activates RPS2-mediated defense signaling ([Fig. 2D](#f2-molce-42-503){ref-type="fig"}) ([@b27-molce-42-503]). AvrRpt2 cleavage products of RIN4 neither interact with RPS2 nor inhibit RPS2-mediated defense signaling ([@b15-molce-42-503]). The activation of RPS2-mediated defense signaling is also regulated by RIN4--NDR1 complex ([@b12-molce-42-503]). The absence of NDR1-RIN4 interaction blocks hypersensitive response after AvrRpt2 inoculation. The ectopic activation of RPS2 is independent of NDR1 and the contribution of NDR1 in AvrRpt2-induced activation of RPS2 requires its interaction with RIN4 ([@b15-molce-42-503]).

Additional effector proteins that modify RIN4
---------------------------------------------

*P. syringae* pv. *tomato* DC3000 type III effector HopF2 contains a myristoylation sequence, which is required for its localization to the plasma membrane ([@b40-molce-42-503]). HopF2 binds with RIN4 or RIN4-associated complex in the membrane, and suppresses AvrRpt2-induced RIN4 degradation and hypersensitive response, without interfering with AvrRpt2 maturation by ROC1 ([Fig. 2D](#f2-molce-42-503){ref-type="fig"}). RPM1 and RPS2 have no effect on the virulence function of HopF2 ([@b50-molce-42-503]). Although the HopF2-mediated RIN4 modification pathway has not yet been established, a recent study shows that HopF2 mediates stomatal regulation through its interaction with AHA2 ([@b20-molce-42-503]). It would be interesting to determine the mechanism of HopF2-mediated RIN4 modification and its effect on plant immunity.

Arabidopsis RIN4 and its homolog in tomato interact with the N-terminal end of unrelated bacterial effectors, AvrPto and AvrPtoB. AvrPto degrades RIN4 in a Pto- (a protein kinase) and Prf- (NB-LRR protein) dependent manner using the same site as used by AvrRpt2. Two additional effectors with unrelated sequences, which also induce RIN4 degradation, include HopQ1-1 DC3000 (HopPtoQ DC3000) and HopAM1 DC3000 (AvrPpiB DC3000). The mode of action of these remain unknown ([Fig. 3](#f3-molce-42-503){ref-type="fig"}) ([@b31-molce-42-503]).

CONCLUSION AND PERSPECTIVES
===========================

Protein complex formation and protein function are very important aspects of plant immunity. RIN4 is a crucial regulator of plant immunity, the absence or modification of which activates various immune responses ([Fig. 3](#f3-molce-42-503){ref-type="fig"}). However, several aspects of RIN4-interacting proteins and their functions in defense signaling need further investigation. Exosomes transport immune system components within the cell and in the apoplast ([@b31-molce-42-503]). It would be interesting to investigate the involvement of RIN4 in intercellular signaling, as it is present in exosomes and interacts with exocyst components EXO70E2 and EXO70B1. RIN4 can recruit one of the exocyst subunit Exo70B1 to the plasma membrane wherein upon AvrRpt2 delivery, both RIN4 and Exo70B1 can be released from plasma membrane to cytoplasm ([@b42-molce-42-503]). Other RIN4-interacting proteins, such as Remorins and Jacalin domain-containing proteins, are involved in response biotic stress; therefore, their involvement in RIN4-mediated plant immunity should be investigated ([@b17-molce-42-503]; [@b39-molce-42-503]). AvrRpm1 induces RIN4 phosphorylation, in part via RIPK or other RLCK kinases and in part by itself, as it has PARP1-like catalytic activity. AvrRpm1 family of type III effectors shares the PARP catalytic fold including key catalytic and structural components of PARP such as the catalytic triad H862-Y907-E998, which facilitates ribosylation reaction ([@b7-molce-42-503]). It would be interesting to identify other kinases induced by AvrRpm1. The RLCK family members BIK1 or PBL1 are ideal candidates for further investigation. RIN4 phosphorylation induced by AvrB and AvrRpm1 increases its activation and association with AHA. However, this phosphorylation is monitored by resistance proteins; therefore, another effector (HopF2) interacts with AHA2 and inhibits stomatal closure. Determining the role of AvrB- and AvrRpm1-mediated RIN4 phosphorylation, in combination with HopF2, would provide further insight into the regulation of stomatal immunity.
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![Effector-mediated RIN4 modification inhibits PTI\
(A) RIN4 negatively regulates PAMP-triggered immunity. (B) PAMP perception by PRR and PRPs increases FLS2-dependent RIN4 phosphorylation at the S141 residue and contributes to PTI. (C) In the absence of RPM1, two effector proteins, AvrB and AvrRpm1, induce RIN4^T166^ phosphorylation, which is epistatic to RIN4^S141^ phosphorylation, and repress PTI activation. (D) Activation and inactivation of AHA1 and AHA2 control stomata opening and closing. (E) RIN4 binds to the C-terminal region of H^+^-ATPase and activates it. The effectors AvrRpm1 and AvrB phosphorylate RIN4^T166^, resulting in increased association of RIN4 with H^+^-ATPase and activation of H^+^-ATPase. AvrRpt2: ![](molce-42-503f4.jpg), AvrB: ![](molce-42-503f5.jpg), AvrRpm1: ![](molce-42-503f6.jpg), RIPK: ![](molce-42-503f7.jpg).](molce-42-503f1){#f1-molce-42-503}

![Type III effectors modify RIN4 to promote bacterial growth and activate resistance proteins\
(A) In *rpm1* mutant plants, the type III effectors, AvrRpm1 and AvrB, phosphorylate RIN4 to promote bacterial growth. ROC1 isomerizes RIN4^P149^ and inhibits RPS2. (B) In resistant plants, ROC1 suppresses RPM1 and RPS2. RIN4 phosphorylation at the T166 residue removes ROC1 suppression and activates RPM1. RPM1 activation initiates a hypersensitive response and decreases bacterial growth. AvrPphB inhibits AvrB-induced RPM1 activation. (C) The type III effector AvrRpt2 cleaves RIN4 upon delivery and processing. In *rps2* mutant plants, AvrRpt2 cleaves RIN4 to promote bacterial growth. RIN4 cleavage subsequently decreases the accumulation of RPM1. (D) In resistant plants, RIN4 degradation activates RPS2, which initiates hypersensitive response and decreases bacterial growth. The RIN4--NDR1 association is important for RPS2 activation. RIN4 degradation activates the resistance protein RPS2, and HopF2 inhibits AvrRpt2-mediated RIN4 cleavage. AvrRpt2: ![](molce-42-503f4.jpg), AvrB: ![](molce-42-503f5.jpg), AvrRpm1: ![](molce-42-503f6.jpg), RIPK: ![](molce-42-503f7.jpg), ROC1: ![](molce-42-503f8.jpg), NDR1: ![](molce-42-503f9.jpg).](molce-42-503f2){#f2-molce-42-503}

![A model depicting the role of RIN4 in PTI and ETI\
RIN4 negatively regulates PTI response upon PAMP recognition (orange). RIN4 strongly binds to the C-terminal inhibitory region of H^+^-ATPase and activates H^+^-ATPase to control stomatal immunity (orange). The effector proteins AvrB and AvrRpm1 induce RIN4 phosphorylation and activate RPM1, if present (green). Another effector, AvrRpt2, degrades RIN4 and activates RPS2, if present (blue). RIN4 degradation also interfere with RPM1 accumulation and function. Expression of the effector protein HopF2 halts AvrRpt2-mediated RIN4 degradation (black). AvrPto and AvrPtoB also degrade RIN4 (purple).](molce-42-503f3){#f3-molce-42-503}

###### 

List of RIN4 (AT3G25070)-associated proteins along with their gene identifiers and functions

  RIN4-associated proteins (RAPs)                                  Gene identifier                 Function                                  References
  ---------------------------------------------------------------- ------------------------------- ----------------------------------------- --------------------------------------------
  RPM1 (resistance to *Pseudomonas syringae* pv. *maculicola* 1)   At3G07040                       Resistant protein that guards RIN4        ([@b34-molce-42-503])
  RPS2 (resistance to *P. syringae* 2)                             At4G26090                       Resistant protein that guards RIN4        ([@b5-molce-42-503]; [@b34-molce-42-503])
  NDR1 (nonrace-specific disease resistance 1)                     At3G20600                       RIN4--NDR1 required for RPS2 function     ([@b15-molce-42-503])
  ROC1 (rotamase CYP 1)                                            At4G38740                       Regulates RPM1 & RPS2 activation          ([@b11-molce-42-503])
  RIPK (RPM1-induced protein kinase)                               At2G05940                       Phosphorylates RIN4                       ([@b30-molce-42-503])
  MPK4 (MAP kinase 4)                                              At4G01370                       Phosphorylates RIN4                       ([@b13-molce-42-503])
  FLS2 (flagellin-sensitive 2)                                     At5G46330                       Controls RIN4 phosphorylation at S141     ([@b10-molce-42-503])
  AHA1 (H^+^-ATPase 1)                                             At2G18960                       Regulates stomata                         ([@b28-molce-42-503]; [@b29-molce-42-503])
  AHA2 (H^+^-ATPase 2)                                             At4G30190                       Regulates stomata                         ([@b28-molce-42-503]; [@b29-molce-42-503])
  Cys/His rich proteins                                            At3G46810                       Involved in intracellular signaling       ([@b1-molce-42-503])
  ERD4 (early responsive to dehydration 4)                         At1G30360                       Upregulates upon abiotic stress           ([@b29-molce-42-503])
  Remorin                                                          At3G61260                       Immunity signaling component              ([@b29-molce-42-503])
  MATH domain (*Meprin And TRAF Homology*)                         At3G28220                       Protein interactor                        ([@b29-molce-42-503])
  Jacalin domain                                                   At3G16420                       Upregulates upon biotic stress            ([@b30-molce-42-503])
  Phloem filament protein                                          At3G01670                       Required for filament formation           ([@b3-molce-42-503])
  EXO70E2 Exo70B1 (component of exocyst complex)                   At5G61010, At5G58430            Vesicle trafficking                       ([@b1-molce-42-503]; [@b42-molce-42-503])
  Pto (serine/threonine protein kinase)                            *Solanum lycopersicum* P93215   Binds with AvrPto and activates defense   ([@b31-molce-42-503])

###### 

RIN4 (AT3G25070) modifier effectors and their mode of action

  Effector               Origin                                                                       Mode of action                                     References
  ---------------------- ---------------------------------------------------------------------------- -------------------------------------------------- ------------------------------------------------------------------------------------
  *AvrB*                 *Pseudomonas syringae* pv. *glycinea* P13835                                 Induces RIN4 phosphorylation                       ([@b5-molce-42-503]; [@b9-molce-42-503]; [@b30-molce-42-503]; [@b34-molce-42-503])
  *AvrRpm1*              *P. syringae* pv. *maculicola* Q7BE94                                        Induces RIN4 phosphorylation                       ([@b9-molce-42-503]; [@b30-molce-42-503]; [@b34-molce-42-503])
  *AvrRpt2*              *P. syringae* pv. *tomato* Q6LAD6                                            Cleaves RIN4 at two sites                          ([@b33-molce-42-503])
  *AvrPto*               *P. syringae* pv. *tomato* [Q87Y16](http://www.uniprot.org/uniprot/Q87Y16)   Degrades RIN4 in a Pto- and Prf-dependent manner   ([@b31-molce-42-503])
  *AvrPtoB*              *P. syringae* pv. *tomato* A5AC83                                            Degrades RIN4                                      ([@b32-molce-42-503])
  *HopF2*                *P. syringae* pv. *tomato* Q88A90                                            Inhibits *AvrRpt2*-mediated RIN4 degradation       ([@b50-molce-42-503])
  *HopPtoQ1-1~DC3000~*   *P. syringae* pv. *tomato* Q888Y7                                            Degrades RIN4                                      ([@b31-molce-42-503])
  *HopAM1~DC3000~*       *P. syringae* pv. *tomato* Q877R9                                            Degrades RIN4                                      ([@b31-molce-42-503])

[^1]: These authors contributed equally to this work.
